Turnšek, N., Devjak, R., Edelbaher, N., Osrajnik, I., Unk, M., Vidovič, D., Jerič, T., & Janžič, U. (2022). Real-world outcomes, treatment patterns and T790M testing rates in Non-Small Cell Lung Cancer patients treated with first-line first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors from the Slovenian cohort of the REFLECT: Outcomes and treatments of EGFR-mutated NSCLC patients from Slovenia. Radiology and Oncology, 56(3), 371–379. Retrieved from https://radioloncol.com/index.php/ro/article/view/3840